The largest database of trusted experimental protocols

Enzyme linked immunosorbent assay

Manufactured by Fujirebio
Sourced in Belgium

Enzyme-linked immunosorbent assays (ELISAs) are a type of laboratory equipment used to detect and quantify specific proteins, hormones, antibodies, and other molecules in a sample. ELISAs utilize antibodies and color changes to identify and measure the concentration of target analytes. The core function of ELISAs is to provide a sensitive and reliable method for immunodetection and quantification of analytes in various biological samples.

Automatically generated - may contain errors

10 protocols using enzyme linked immunosorbent assay

1

CSF Biomarkers in Alzheimer's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each subject was categorized according to clinical diagnosis (NC, MCI, AD dementia; Table 1). Established CSF AD biomarkers (Aβ42, total tau [t-Tau], and tau phosphorylated at threonine 181 [p-Tau181]) were measured in the middle-aged cohort (n=68) using enzyme-linked immunosorbent assays (Fujirebio, Ghent, Belgium) in the Zetterberg lab, and the same markers were previously measured in the older cohort using Luminex-based multiplex assays (Fujirebio US, Malvern, PA) in Atlanta. We have performed cross-platform validation studies at Emory to show strong linear correlation between these two platforms.22 (link)
+ Open protocol
+ Expand
2

Cerebrospinal Fluid Biomarker Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
A subset of individuals (155 participants) completed an optional morning fasting lumbar puncture. CSF was collected with polypropylene syringes using a Sprotte 25-gauge spinal needle in the L3/L4 or L4/L5 intervertebral lumbar space. Samples were immediately mixed and centrifuged, and supernatants were aliquoted in 0.5 mL polypropylene tubes and stored at −80 °C. Samples were analyzed in batch using commercially available enzyme-linked immunosorbent assays (Fujirebio, Ghent, Belgium) to determine the levels of Aβ1–42 (INNOTEST® β-AMYLOID(1–42)), total tau (INNOTEST® hTAU), and tau phosphorylated at threonine 181 (P-tau; INNOTEST® PHOSPHO-TAU(181P)). NFL was measured using a commercially available ELISA (UmanDiagnostics). Processing was completed by board-certified laboratory technicians who were blinded to clinical information (Palmqvist et al., 2014 (link)). Intraassay coefficients of variation were <10%.
+ Open protocol
+ Expand
3

CSF Biomarkers for Neurodegeneration

Check if the same lab product or an alternative is used in the 5 most similar protocols
A subset of participants completed an optional fasting lumbar puncture at
enrollment (n=155, Fig. 1). CSF was
collected with polypropylene syringes using a Sprotte 25-gauge spinal needle in
an intervertebral lumbar space. Samples were immediately mixed and centrifuged.
Supernatants were aliquoted in 0.5 mL polypropylene tubes and stored at
−80°C. Samples were analyzed in single batch using a
commercially available enzyme-linked immunosorbent assay (Uman Diagnostics) to
measure CSF NFL concentration. Commercially available enzyme-linked
immunosorbent assays (Fujirebio, Ghent, Belgium) were used to measure CSF
concentrations of Aβ42 (INNOTEST®β-AMYLOID(1–42)) and t-tau
(INNOTEST® hTAU). Board certified laboratory technicians
processed data blinded to clinical information (Palmqvist et al., 2014 (link)). Intra-assay coefficients of variation were
<10%.
+ Open protocol
+ Expand
4

CSF Biomarkers Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, an optional baseline, fasting, lumbar puncture procedure aided CSF collection using a polypropylene syringe and a Sprotte 25-gauge spinal needle from an intervertebral lumbar space. CSF supernatant was immediately extracted and stored at -80 °C. Commercially available kits were used for the measurement of CSF total tau, p-tau181, Aβx-40, Aβx-42, Aβ1-42, neurofilament light (NfL) and albumin concentrations, performed in batch, as previously described. Albumin was measured in both CSF and plasma by immunonephelometry [15 (link)]. A Meso Scale Discovery (MSD) assay (Rockville, MD) was used to measure sTREM2 levels in CSF, described by Jensen et al., 2019 [27 (link)]. Commercially available enzyme-linked immunosorbent assays (Fujirebio, Ghent, Belgium) were used to determine the levels of Aβ42 (INNOTEST β-AMYLOID(1–42)) and the subsequent Aβ42/Aβ40 ratio [24 (link)]. Biotinylated polyclonal goat anti-human TREM2 capture antibodies (R&D Systems BAF1828) were incubated with recombinant human TREM2 protein (Sino Biological Inc. 11084-H08H) and a SULFO-TAG–labeled anti-mouse secondary antibody was used for detection. More detailed kit information is provided in Supplemental Table 1.
+ Open protocol
+ Expand
5

CSF Biomarker Analysis in Neurodegenerative Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
A subset of participants completed an optional morning fasting lumbar puncture at enrollment (n = 55, Supplementary Figure 1). CSF was collected with polypropylene syringes using a Sprotte 25-gauge spinal catheter. Samples were immediately centrifuged, aliquoted into 0.5 mL polypropylene tubes, and stored at −80°C. Samples were analyzed in single batch, and commercially available enzyme-linked immunosorbent assays (Fujirebio, Ghent, Belgium) were used to measure CSF concentrations of Aβ42 [INNOTEST® β-AMYLOID(1–42)], phosphorylated tau [p-tau, INNOTEST® PHOSPHO-TAU(181P)], total tau (t-tau, INNOTEST® hTAU), neurogranin (Kvartsberg et al., 2015 (link)), and NFL (Uman Diagnostics). Board certified laboratory technicians processed samples blinded to clinical information (Palmqvist et al., 2014 (link)). Intra-assay coefficients of variation were < 10% (Kvartsberg et al., 2015 (link)).
+ Open protocol
+ Expand
6

Lumbar Puncture and CSF Biomarker Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A subset of participants completed a fasting lumbar puncture (n = 104). CSF was collected with polypropylene syringes using a Sprotte 25-gauge spinal needle in an intervertebral lumbar space. Samples were immediately mixed and centrifuged, and supernatants were aliquoted in 0.5 mL polypropylene tubes and stored at −80 °C. Samples were analyzed in batch using commercially available enzyme-linked immunosorbent assays (Fujirebio, Ghent, Belgium) to determine the levels of Aβ42 (INNOTEST β-AMYLOID(1–42)), p-tau (INNOTEST PHOSPHO-TAU(181P)), and t-tau (INNOTEST hTAU) (Osborn et al., 2018 (link)). Board-certified laboratory technicians processed data blinded to clinical information, as previously described (Palmqvist et al., 2014 (link)).
+ Open protocol
+ Expand
7

Cerebrospinal Fluid Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
At baseline, participants were invited to complete an optional fasting
lumbar puncture procedure. CSF was collected with polypropylene syringes using a
Sprotte 25-gauge spinal needle in an intervertebral lumbar space. Samples were
immediately mixed and centrifuged, and supernatants were aliquoted in 0.5mL
polypropylene tubes and stored at −80°C. Samples were analyzed
in batch using commercially available enzyme-linked immunosorbent assays
(Fujirebio, Ghent, Belgium) to determine the levels of Aβ42(INNOTEST® β-AMYLOID(1-42)),
p-tau* (INNOTEST® PHOSPHO-TAU(181P)), and
t-tau (INNOTEST® hTAU). P-tau was measured by tagging a tau
phosphorylation site at amino acid Thr181. This form of phosphorylated tau
appears most specific to AD and correlates with tangle pathology (Buerger et al., 2006 (link); Seppala et al., 2012 (link)). NFL was measured using a commercially
available enzyme-linked immunosorbent assay (Uman Diagnostics). Board-certified
laboratory technicians processed data blinded to clinical information, as
previously described (Palmqvist et al.,
2014
). Intra-assay coefficients of variation were <10
percent.
+ Open protocol
+ Expand
8

CSF Biomarkers Measurements Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CSF was collected by lumbar puncture between 9 and 12 AM. Samples were processed within 1 hour, centrifuged at 4°C for 10 minutes at 2000× g and stored in polypropylene tubes at −80°C. CSF Aβ42, p-tau, and t-tau levels detection was performed by enzyme-linked immunosorbent assay from Innogenetics (Ghent, Belgium). Determination of the CSF YKL-40 followed the procedure described in [37] (link), and determination of the CSF sTREM2 was according the process described in [33] (link).
+ Open protocol
+ Expand
9

CSF Biomarkers for Alzheimer's Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aβ42 and t-tau protein concentrations were our CSF biomarkers. CSF was collected in polypropylene tubes and obtained by lumbar puncture performed with a 20- or 24-gauge spinal needle between L4 and L5 or L3 and L4. The samples were maintained at +4°C and afterward, centrifuged at 2000 × g for 5 minutes, then aliquoted and stored at −80°C. Finally, a commercially available enzyme-linked immunosorbent assay (Innogenetics, Ghent, Belgium) was used to determine Aβ42 and t-tau protein concentrations.
+ Open protocol
+ Expand
10

Cerebrospinal Fluid Biomarkers for Alzheimer's

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects underwent lumbar puncture in the morning (9-12 AM). CSF samples were centrifuged and stored in polypropylene tubes at À80°C. The AB42, tau, and p-tau at threonine 181 in CSF were measured by enzyme-linked immunosorbent assay (Innogenetics, Ghent, Belgium). Cut-off values of abnormality for each CSF biomarker were defined according to previous works (Antonell et al., 2011; (link)van Harten et al., 2013) (link): AB42 < 550 pg/ml, tau > 450 pg/ml, and p-tau > 75 pg/ml.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!